Bristol-Myers Squibb Co (N:BMY)

Business Focus: Pharmaceuticals

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Pfizer (N:PFE)
Odonate Therapeutics (OQ:ODT)
Latest 10 SEC filings (by transaction date) for BMY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 12/19 Jun 10/19 Powell Ann Direct Ownership Common Stock, $0.10 par value J - Other transaction -41,546  
May 20/19 May 16/19 Santiago Karen Murphy Direct Ownership Common Stock, $0.10 par value S - Open market or private sale -3,065 $47.56
May 20/19 May 16/19 Samuels Theodore R. II Direct Ownership Common Stock, $0.10 par value P - Open market or private purchase 5,000 $47.29
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Market Share Units M - Exercise or conversion exempt under rule 16b-3 8,040  
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Common Stock, $0.10 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,774 $48.62
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Common Stock, $0.10 par value J - Other transaction -2,399  
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Common Stock, $0.10 par value M - Exercise or conversion exempt under rule 16b-3 8,040  
Apr 5/19 Apr 3/19 Lynch Thomas J. Jr. Direct Ownership Market Share Units M - Exercise or conversion exempt under rule 16b-3 -5,298  
Apr 5/19 Apr 3/19 Lynch Thomas J. Jr. Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -6,296  
Apr 5/19 Apr 3/19 Lynch Thomas J. Jr. Direct Ownership Common Stock, $0.10 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,820 $46.88
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BMY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 12/19 Jun 10/19 Powell Ann Direct Ownership Common Stock, $0.10 par value J - Other transaction -41,546  
May 20/19 May 16/19 Santiago Karen Murphy Direct Ownership Common Stock, $0.10 par value S - Open market or private sale -3,065 $47.56
May 20/19 May 16/19 Samuels Theodore R. II Direct Ownership Common Stock, $0.10 par value P - Open market or private purchase 5,000 $47.29
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Market Share Units M - Exercise or conversion exempt under rule 16b-3 8,040  
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Common Stock, $0.10 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,774 $48.62
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Common Stock, $0.10 par value J - Other transaction -2,399  
May 6/19 May 5/19 Caforio Giovanni Direct Ownership Common Stock, $0.10 par value M - Exercise or conversion exempt under rule 16b-3 8,040  
May 6/19 Oct 2/18 Biondi Paul Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -592  
May 6/19 Oct 2/18 Biondi Paul Direct Ownership Common Stock, $0.10 par value F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -292 $62.80
May 6/19 Oct 2/18 Biondi Paul Direct Ownership Common Stock, $0.10 par value M - Exercise or conversion exempt under rule 16b-3 592  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $BMY

StockTwits